Monopar Therapeutics
MNPR
MNPR
43 hedge funds and large institutions have $113M invested in Monopar Therapeutics in 2025 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 15 increasing their positions, 4 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
+8
Holders Change %
+22.86%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
15
Reduced
4
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$6.82M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.73M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$1.35M |
| 4 |
ABG
Ally Bridge Group
New York
|
+$1.24M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.12M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.29M |
| 2 |
Millennium Management
New York
|
-$1.63M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$946K |
| 4 |
Goldman Sachs
New York
|
-$673K |
| 5 |
Jane Street
New York
|
-$377K |